Innospec (NASDAQ:IOSP) Lowered to "Hold" Rating by Wall Street Zen

Key Points

• Innospec was downgraded by Wall Street Zen from a buy to a hold rating, adding to a broader trend of mixed analyst sentiment; MarketBeat says the stock currently carries an average Hold rating.
• The company beat first-quarter expectations, reporting EPS of $1.05 on revenue of $453.2 million, both above analyst estimates, even though earnings were down from a year earlier.
• Management also signaled confidence in cash flow by raising its semi-annual dividend 10% to $0.92 per share and authorizing a new $75 million share buyback.

Innospec (NASDAQ:IOSP - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued on Saturday.

IOSP has been the topic of a number of other research reports. Weiss Ratings upgraded shares of Innospec from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, February 19th. Zacks Research upgraded shares of Innospec from a "strong sell" rating to a "hold" rating in a report on Friday, April 24th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of "Hold".

Innospec Price Performance

IOSP opened at $80.55 on Friday. Innospec has a fifty-two week low of $65.51 and a fifty-two week high of $95.55. The firm has a market capitalization of $2.00 billion, a PE ratio of 17.55, a P/E/G ratio of 2.06 and a beta of 0.90. The company's 50-day moving average is $73.65 and its 200 day moving average is $76.59.

Innospec (NASDAQ:IOSP - Get Free Report) last posted its earnings results on Thursday, May 7th. The specialty chemicals company reported $1.05 earnings per share for the quarter, topping analysts' consensus estimates of $1.02 by $0.03. Innospec had a net margin of 6.38% and a return on equity of 9.39%. The company had revenue of $453.20 million for the quarter, compared to analyst estimates of $432.14 million. During the same quarter in the prior year, the business posted $1.42 EPS. The firm's revenue was up 2.8% compared to the same quarter last year. As a group, analysts expect that Innospec will post 4.96 EPS for the current year.

Insider Activity

In other Innospec news, Director Milton C. Blackmore sold 594 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $76.56, for a total value of $45,476.64. Following the completion of the sale, the director owned 10,530 shares in the company, valued at approximately $806,176.80. This trade represents a 5.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director David Landless sold 594 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $76.56, for a total transaction of $45,476.64. Following the completion of the sale, the director owned 7,632 shares of the company's stock, valued at approximately $584,305.92. This trade represents a 7.22% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 4,989 shares of company stock worth $391,889. Corporate insiders own 1.45% of the company's stock.

Institutional Investors Weigh In On Innospec

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC raised its position in Innospec by 1,159.5% in the second quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company's stock worth $44,000 after acquiring an additional 487 shares during the period. Versant Capital Management Inc grew its position in shares of Innospec by 378.1% during the 3rd quarter. Versant Capital Management Inc now owns 545 shares of the specialty chemicals company's stock valued at $42,000 after acquiring an additional 431 shares during the period. Hantz Financial Services Inc. grew its position in shares of Innospec by 271.0% during the 4th quarter. Hantz Financial Services Inc. now owns 575 shares of the specialty chemicals company's stock valued at $44,000 after acquiring an additional 420 shares during the period. Allworth Financial LP grew its position in shares of Innospec by 31.0% during the 3rd quarter. Allworth Financial LP now owns 588 shares of the specialty chemicals company's stock valued at $45,000 after acquiring an additional 139 shares during the period. Finally, Danske Bank A S bought a new position in shares of Innospec during the 3rd quarter valued at approximately $46,000. Hedge funds and other institutional investors own 96.64% of the company's stock.

Key Innospec News

Here are the key news stories impacting Innospec this week:

• Positive Sentiment: Innospec beat analyst estimates with Q1 EPS of $1.05 versus $1.02 expected, and revenue of $453.2 million versus $432.1 million expected, which suggests the business held up better than Wall Street anticipated. Innospec Q1 2026 earnings release
• Positive Sentiment: The company raised its semi-annual dividend by 10% to $0.92 per share and approved a new $75 million share buyback authorization, reinforcing confidence in cash generation and shareholder returns. Innospec Q1 2026 financial results
• Positive Sentiment: Fuel Specialties remained a standout, with revenue up 7% and operating income up 2%, helping offset weakness elsewhere in the portfolio. Innospec Q1 2026 earnings call transcript
• Neutral Sentiment: Management said the quarter was mixed, with a winter storm disrupting Performance Chemicals and Oilfield Services, but it expects sequential improvement in the second quarter as repairs and operational fixes continue. TipRanks summary of Innospec Q1 results
• Negative Sentiment: Profitability was pressured by the storm impact: adjusted non-GAAP EPS fell to $1.05 from $1.42 a year ago, and Performance Chemicals operating income dropped 46% year over year. Zacks earnings coverage

Innospec Company Profile

Innospec Incorporated NASDAQ: IOSP is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.